vs
六旗（FUN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
六旗的季度营收约是Orthofix Medical Inc.的1.0倍（$225.6M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -119.0%，领先118.0%），六旗同比增速更快（11.7% vs 2.0%）
六旗娱乐是总部位于美国北卡罗来纳州夏洛特的游乐园运营企业，由雪松会与原六旗公司于2024年7月1日对等合并而成，是全球最大的区域性游乐园运营商。旗下共运营42个场地，包含27座游乐园、15座水上乐园，配套9处 onsite 度假物业。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FUN vs OFIX — 直观对比
营收规模更大
FUN
是对方的1.0倍
$219.9M
营收增速更快
FUN
高出9.7%
2.0%
净利率更高
OFIX
高出118.0%
-119.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $225.6M | $219.9M |
| 净利润 | $-268.6M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | — | 0.2% |
| 净利率 | -119.0% | -1.0% |
| 营收同比 | 11.7% | 2.0% |
| 净利润同比 | -22.2% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUNOFIX
| Q1 26 | $225.6M | — | ||
| Q4 25 | $650.1M | $219.9M | ||
| Q3 25 | $1.3B | $205.6M | ||
| Q2 25 | $930.4M | $203.1M | ||
| Q1 25 | $202.1M | $193.6M | ||
| Q4 24 | — | $215.7M | ||
| Q3 24 | $1.3B | $196.6M | ||
| Q2 24 | $571.6M | $198.6M |
净利润FUNOFIX
| Q1 26 | $-268.6M | — | ||
| Q4 25 | $-92.4M | $-2.2M | ||
| Q3 25 | $-1.2B | $-22.8M | ||
| Q2 25 | $-99.6M | $-14.1M | ||
| Q1 25 | $-219.7M | $-53.1M | ||
| Q4 24 | — | $-29.1M | ||
| Q3 24 | $111.0M | $-27.4M | ||
| Q2 24 | $55.6M | $-33.4M |
毛利率FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | 91.4% | 71.1% | ||
| Q3 25 | 91.6% | 72.2% | ||
| Q2 25 | 91.3% | 68.7% | ||
| Q1 25 | 89.3% | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | 91.9% | 68.7% | ||
| Q2 24 | 90.7% | 67.8% |
营业利润率FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | -3.8% | 0.2% | ||
| Q3 25 | -83.7% | -8.3% | ||
| Q2 25 | 8.0% | -7.9% | ||
| Q1 25 | -158.9% | -25.2% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 19.5% | -9.6% | ||
| Q2 24 | 21.6% | -12.5% |
净利率FUNOFIX
| Q1 26 | -119.0% | — | ||
| Q4 25 | -14.2% | -1.0% | ||
| Q3 25 | -90.1% | -11.1% | ||
| Q2 25 | -10.7% | -6.9% | ||
| Q1 25 | -108.7% | -27.4% | ||
| Q4 24 | — | -13.5% | ||
| Q3 24 | 8.2% | -13.9% | ||
| Q2 24 | 9.7% | -16.8% |
每股收益（稀释后）FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-0.93 | $-0.05 | ||
| Q3 25 | $-11.77 | $-0.57 | ||
| Q2 25 | $-0.99 | $-0.36 | ||
| Q1 25 | $-2.20 | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | $1.10 | $-0.71 | ||
| Q2 24 | — | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $116.5M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $279.2M | $450.0M |
| 总资产 | $7.7B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FUNOFIX
| Q1 26 | $116.5M | — | ||
| Q4 25 | $91.1M | $82.0M | ||
| Q3 25 | $70.7M | $62.9M | ||
| Q2 25 | $107.4M | $65.6M | ||
| Q1 25 | $61.5M | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | $89.7M | $30.1M | ||
| Q2 24 | $52.9M | $26.4M |
总债务FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | — | ||
| Q3 25 | $5.0B | $157.2M | ||
| Q2 25 | $5.3B | $157.0M | ||
| Q1 25 | $5.0B | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | $4.6B | $118.5M | ||
| Q2 24 | $2.3B | $118.0M |
股东权益FUNOFIX
| Q1 26 | $279.2M | — | ||
| Q4 25 | $549.8M | $450.0M | ||
| Q3 25 | $614.3M | $442.5M | ||
| Q2 25 | $1.8B | $458.3M | ||
| Q1 25 | $1.8B | $458.3M | ||
| Q4 24 | — | $503.1M | ||
| Q3 24 | $2.3B | $525.9M | ||
| Q2 24 | — | $546.0M |
总资产FUNOFIX
| Q1 26 | $7.7B | — | ||
| Q4 25 | $7.8B | $850.6M | ||
| Q3 25 | $7.9B | $832.6M | ||
| Q2 25 | $9.5B | $837.2M | ||
| Q1 25 | $9.2B | $823.1M | ||
| Q4 24 | — | $893.3M | ||
| Q3 24 | $9.4B | $867.9M | ||
| Q2 24 | $2.3B | $882.0M |
负债/权益比FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | 9.40× | — | ||
| Q3 25 | 8.16× | 0.36× | ||
| Q2 25 | 2.97× | 0.34× | ||
| Q1 25 | 2.75× | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | 1.95× | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $27.7M |
| 自由现金流经营现金流 - 资本支出 | — | $16.8M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-37.7M | $27.7M | ||
| Q3 25 | $356.2M | $12.4M | ||
| Q2 25 | $187.0M | $11.6M | ||
| Q1 25 | $-178.0M | $-18.4M | ||
| Q4 24 | — | $23.7M | ||
| Q3 24 | $337.4M | $11.7M | ||
| Q2 24 | — | $9.0M |
自由现金流FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | $-109.3M | $16.8M | ||
| Q3 25 | $256.2M | $2.5M | ||
| Q2 25 | $18.8M | $4.5M | ||
| Q1 25 | $-318.0M | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $227.7M | $6.3M | ||
| Q2 24 | — | $-360.0K |
自由现金流率FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | -16.8% | 7.6% | ||
| Q3 25 | 19.4% | 1.2% | ||
| Q2 25 | 2.0% | 2.2% | ||
| Q1 25 | -157.4% | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | 16.9% | 3.2% | ||
| Q2 24 | — | -0.2% |
资本支出强度FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | 11.0% | 4.9% | ||
| Q3 25 | 7.6% | 4.8% | ||
| Q2 25 | 18.1% | 3.5% | ||
| Q1 25 | 69.3% | 3.5% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | 8.1% | 2.7% | ||
| Q2 24 | — | 4.7% |
现金转化率FUNOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.04× | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUN
| In-park admissions revenues | $113.4M | 50% |
| In-park product revenues | $89.0M | 39% |
| Out-of-park revenues | $28.8M | 13% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
